Nonsteroidal Antiasthma Flashcards
(13 cards)
What is it used for
–control management of mild persistent asthma
–used to prevent symptoms from starting
–has no bronchodilating effect
Mechanism of Inflammation in Asthma: Extrinsic
–Allergic
–dust, smoke, pets
Mechanisms of inflammation in Asthma: Intrinsic
–Nonallergic
–cold air, stress, excerise
3 components of Asthma
–Acute asthma attack:resolves spontaneously or with treatment
–Hyperresponsiveness of airways to various stimuli
–Persistent inflammation that becomes worse
Cromolyn Agent: Cromolyn Sodium
–Trade Name: Disodium cromoglycate
–Mode of Action: prevents mast cell degranulation by blocking the release of chemical mediators if inflammation
–Prevents asthma triggers
–Methos od Admin: SVN 20mg/ampule or 20mg/2ml (1%)
–Side Effects: cough, nasal congestion, wheezing, nasal itching, epistaxis, nose burning
Antileukotriene Agents
–Leukotrienes are potent bronchoconstrictor and stimulate other cells to cause:
-airway edema
-mucus secretion
-ciliary beat inhibition
-recruitment of other inflammatory cells
–Alternative to steroids or cromolyn
–Used for Long-Term control
Antileukotriene Agents: Zileuton
–Trade Name: Zyflo, Zyflo CR
–Rarely Used
–Dosage and Admin: Oral, 600mg tablets,QID
Used in adults and children ages 12+
1hr before and 2 hrs after meals
–Hazards and Side effects: Headache, abdominal pain, loss of strength, dyspepsia
monitor liver function
interacts with theophylline and warfarin
Antileukotriene Agents: Zafirlukast
–Trade Name: Accolate
–Dosage and Admin: Oral admin
10mg, BID children 5/11yrs
20mg, BID 12yrs and older
–Hazards and Side Effects: headache, infection, nausea, diarrhea, generalized abdominal pain, decrease liver function
Antileukotriene Agents: Montelukast
–Trade Name: Singulair
–Dosage and Admin: Oral, 4mg or 10mg, 5mg chewable
Approved for ages 6months and up
–Hazards and side effects: diarrhea, laryngitis, pharyngitis, nausea, sinusitis, viral infection
Advantages
–oral admin
–possible once daily dosing
–safe with few side effects
–effective in aspirin sensitivity and often exercise-induced asthma
–systemic distribution reaches entire lung
–additive effect with inhaled steroids
Disadvantage
antiinflammatory action limited to one mediator pathway
–unknown long-term toxicity
–effective only to 50-70% of pt
–no predictor of pt who will respond
–systemic drug exposure
Monoclonal Antibodies: Omalizumab
–Trade Name: Xolair
–Mode of Action: blocks the attachment of IgE to mast cells reducing inflammatory mediators
–Dosage and Admin: Parenteral, 150mg/ 1.2 mL, every 2 to 4 weeks
–Hazards and side effects: anaphylaxis, injection site reactions, fever, headache, and sore throat
What kind of Asthma is associated with an allergic reaction
–extrinsic